Provider

By Laura Lovett June 21, 2018
Glucose-monitoring lenses have been a continuing area of interest from developers all over the world. Most recently a team of researchers at Purdue University has announced that they have developed a new silicon-based, sensor-carrying lens that can monitor glucose levels as well as be used for ocular pain relief and drug delivery.  The group at Purdue said the technology can...
By Laura Lovett June 21, 2018
Earlier this week medical device maker Masimo and Thermomedics, a Positive ID company, launched their new less, Bluetooth-enabled thermometer in the US market. The thermometer, called TIR-1, will be able to integrate with the Masimo Root patient monitoring and connectivity platform.  "TIR-1 is a great example of the powerful expandability and versatility of the Root platform, and of our...
By Laura Lovett June 20, 2018
In a recent review, an independent group of panelists raised questions about UK-based AI company DeepMind’s business model, relationship with parent company Alphabet, and potential to monopolize its industry.  The Google subsidiary has been partnering with the National Health Service for the last few years and working with the system to implement its AI technology. While the company has been...
By Dave Muoio June 20, 2018
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the...
Mayo Clinic remote patient monitoring startup Ambient Clinical Analytics
By Jonah Comstock June 19, 2018
Ambient Clinical Analytics, a remote patient monitoring company that spun off from Mayo Clinic in 2013, has raised $1.5 million in a round led by Noaber Ventures, the impact investment arm of Noaber Foundation and the company’s first European investor. Existing investors Social Capital, Bluestem Capital, and Mayo Clinic also contributed to the round. “The company is making great progress, and...
By Laura Lovett June 19, 2018
Last week the American Medical Association outlined a new set of recommendations on augmented intelligence, a type of technology that aims to extend, but not replace, a human medical expert’s insight and decision-making capabilities. “As technology continues to advance and evolve, we have a unique opportunity to ensure that augmented intelligence is used to benefit patients, physicians, and the...
Nutrino diabetes app
By Laura Lovett June 19, 2018
Medical tech company Medtronic is teaming up with Nutrino, an AI powered personalized nutrition platform. Nutrino’s FoodPrint Report technology will now be integrated into Medtronic’s iPro2 myLog app, a platform that connects with a continuous glucose monitor to help give users insights about their glucose levels.  The new technology will enable doctors and clinicians to see the food that a...
By Dave Muoio June 18, 2018
To all of the people who work with machine learning and neural networks healthcare technologies, but can’t describe exactly how the gears are turning — don’t worry, you’re not alone. In a sold-out discussion hosted at Optum’s Boston office and organized by the Design Museum Foundation, Sanji Fernando, vice president and head of OptumLabs’ Center for Applied Data Science, explained how the ongoing...
By Laura Lovett June 18, 2018
Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the only partner with a 25-year DBS legacy, and paves the way to our vision of the future of DBS with a fully integrated system from planning to programming," said Mike Daly, vice president and general...
DreaMed Diabetes tool gets FDA approval
By Dave Muoio June 18, 2018
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that can improve people’s lives and the FDA decision confirms what we believe is an important step in making a more meaningful connection between the healthcare provider and their type 1 diabetes patients...